Arcellx, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1286316,
    "name": "Arcellx, Inc.",
    "stock_name": "Arcellx, Inc.",
    "full_name": "Arcellx, Inc.",
    "name_url": "stocks-analysis/arcellx-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "68.45",
    "chg": -0.36,
    "chgp": "-0.52%",
    "dir": -1,
    "prev_price": "68.81",
    "mcapval": "3,943.68",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US03940C1009",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.12 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arcellx-inc-1286316-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Arcellx, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcellx-inc-technically-bullish-or-bearish-3547659",
        "imagepath": "",
        "date": "2025-09-20 20:00:10",
        "description": "As of 4 September 2025, the technical trend for Arcellx, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, supporting the positive stance. Daily moving averages also indicate a bullish trend. The KST is bullish on both weekly and monthly time frames, while Dow Theory shows a mildly bullish signal on both weekly and monthly as well. The stock has outperformed the S&P 500 over the past week and month, with returns of 2.96% and 11.36% compared to 1.05% and 2.33% for the index, respectively. Overall, the current technical stance is bullish with strong indicators supporting this view...."
      },
      {
        "title": "Is Arcellx, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcellx-inc-overvalued-or-undervalued-3543970",
        "imagepath": "",
        "date": "2025-09-20 18:34:03",
        "description": "As of 8 May 2023, the valuation grade for Arcellx, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 9.00, a negative EV to EBIT of -16.87, and a troubling ROE of -38.96%. In comparison to its peers, Arcellx's EV to EBITDA of -17.41 is less favorable than Arrowhead Pharmaceuticals, which stands at -40.56, but significantly worse than Alvotech's 39.96.\n\nDespite the overvaluation, Arcellx has shown strong short-term performance with a 1-week return of 2.96% compared to the S&P 500's 1.05%, and a 1-month return of 11.36% against 2.33% for the index. However, its year-to-date return of 4.29% lags behind the S&P 500's 12.22%, and its 1-year return of -0.71% is notably underwhelming compared to the S&P's 17.14%. Overall, the company's financial metrics and performance suggest it..."
      }
    ],
    "total": 6,
    "sid": "1286316",
    "stock_news_url": "https://www.marketsmojo.com/news/arcellx-inc-1286316"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Arcellx, Inc. technically bullish or bearish?

2025-09-20 20:00:10

As of 4 September 2025, the technical trend for Arcellx, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, supporting the positive stance. Daily moving averages also indicate a bullish trend. The KST is bullish on both weekly and monthly time frames, while Dow Theory shows a mildly bullish signal on both weekly and monthly as well. The stock has outperformed the S&P 500 over the past week and month, with returns of 2.96% and 11.36% compared to 1.05% and 2.33% for the index, respectively. Overall, the current technical stance is bullish with strong indicators supporting this view....

Is Arcellx, Inc. overvalued or undervalued?

2025-09-20 18:34:03

As of 8 May 2023, the valuation grade for Arcellx, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 9.00, a negative EV to EBIT of -16.87, and a troubling ROE of -38.96%. In comparison to its peers, Arcellx's EV to EBITDA of -17.41 is less favorable than Arrowhead Pharmaceuticals, which stands at -40.56, but significantly worse than Alvotech's 39.96. Despite the overvaluation, Arcellx has shown strong short-term performance with a 1-week return of 2.96% compared to the S&P 500's 1.05%, and a 1-month return of 11.36% against 2.33% for the index. However, its year-to-date return of 4.29% lags behind the S&P 500's 12.22%, and its 1-year return of -0.71% is notably underwhelming compared to the S&P's 17.14%. Overall, the company's financial metrics and performance suggest it...

View All News